Serum Institute of India Pvt. Ltd.

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

5 drugs in development

Phase 31

Phase 24

By Therapeutic Area

top 2

Infectious Disease

480%

Oncology

120%

R&D Momentum

32/100

Pipeline Velocity

15/100

Trial Completion Rate

94/100

Pipeline Concentration

68/100

Pipeline Freshness

86/100

Strategic Signals

↗Early-stage heavy pipeline may seek late-stage partners
↗Active in Oncology but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Jul 9, 2026

Active, not recruiting

Phase 2 Randomized, Double-blind, Controlled Study of Pfs230D1-CRM197 With R21 in Matrix-M1 in Healthy African School Children and Adults

Jul 2, 2026

Completed

An Observer-blind, Randomized, Active-controlled, Multi-centric Phase III Study to Assess Immunogenicity and Safety of Hexavalent (DTwP-Hepatitis B-IPV-Hib) Vaccine Containing Reduced Dose IPV in Comparison With HEXASIIL®

Earlier

Jun 30, 2026TrialA Phase-3b, Partially Double-blind, Randomized, Multi-country Clinical Study to Evaluate the Immunogenicity,Safety, and Reactogenicity of SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Years

Aug 30, 2024TrialDose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults

May 11, 2023TrialA Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL

Sep 16, 2022TrialA Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants

Jan 9, 2022TrialEvaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine

Nov 9, 2020TrialEvaluation of Efficacy and Safety of VPM1002 in Comparison to BCG in Prevention of Tb Infection in Infants

3 more events

Dec 27, 2019TrialStudy to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine and to Compare Its Safety and Immunogenicity With That of Licensed Meningococcal ACWY Vaccine Menactra® in Healthy Individuals 18-85 Years of Age

Dec 17, 2019TrialA Phase 1 Safety Study of Dengusiil in Healthy Adults

Aug 20, 2019TrialStudy to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)